Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Clinical Molecular Genetics Laboratory, |
RCV000984479 | SCV001021976 | uncertain significance | Familial atrioventricular septal defect | 2019-12-09 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002354890 | SCV002656267 | uncertain significance | Inborn genetic diseases | 2018-06-04 | criteria provided, single submitter | clinical testing | The p.V2030I variant (also known as c.6088G>A), located in coding exon 29 of the CHD7 gene, results from a G to A substitution at nucleotide position 6088. The valine at codon 2030 is replaced by isoleucine, an amino acid with highly similar properties. This amino acid position is poorly conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |
Fulgent Genetics, |
RCV002488072 | SCV002777504 | uncertain significance | CHARGE syndrome; Hypogonadotropic hypogonadism 5 with or without anosmia | 2022-04-14 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV002549627 | SCV003256545 | likely benign | CHARGE syndrome | 2024-12-24 | criteria provided, single submitter | clinical testing |